Cargando…

Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Intrahepatic portal hypertension accounts for most of the morbidity and mortality encountered in patients with liver cirrhosis, due to increased portal inflow and intrahepatic vascular resistance. Most treatments have focused only on portal inflow or vascular resistance. However, miRNA multitarget r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Can-Jie, Pan, Qin, Xiong, Hua, Qiao, Yu-Qi, Bian, Zhao-Lian, Zhong, Wei, Sheng, Li, Li, Hai, Shen, Lei, Hua, Jing, Ma, Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000931/ https://www.ncbi.nlm.nih.gov/pubmed/24812632 http://dx.doi.org/10.1155/2014/797898

Ejemplares similares

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis
por: Jiao, Pan, et al.
Publicado: (2022)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for repeated bleeding of hemorrhoids caused by severe portal hypertension with ectopic varices: A case report
por: Shi, Qin, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Bleeding oesophageal varices in the absence of intrahepatic or extrahepatic obstruction of the portal system and without portal hypertension.
por: Johnston, G. W.
Publicado: (1965)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study
por: Zhang, Yu, et al.
Publicado: (2019)

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
por: Balducci, Daniele, et al.
Publicado: (2023)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
por: Lee, Hae Lim, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for pediatric portal hypertension: A meta-analysis
por: Raissi, Driss, et al.
Publicado: (2023)

Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt via jugular vein
por: Yao, Xin, et al.
Publicado: (2022)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertensive biliopathy with cavernous transformation of the portal vein: a case report
por: Zhao, Ming, et al.
Publicado: (2022)

Assessment of intrahepatic blood flow by Doppler ultrasonography: Relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension
por: Zhang, Li, et al.
Publicado: (2011)

Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt
por: Li, Yingying, et al.
Publicado: (2021)

A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients
por: Liao, Yong, et al.
Publicado: (2023)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series
por: Zheng, Dan, et al.
Publicado: (2021)

Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway
por: Chen, Yunyang, et al.
Publicado: (2016)

Advances in therapeutic options for portal hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018)

Emerging Therapeutic Targets for Portal Hypertension
por: Felli, Eric, et al.
Publicado: (2023)

Portal Hypertension, Variceal Bleeding, and High Output Cardiac Failure Secondary to an Intrahepatic Arterioportal Fistula
por: Oishi, Andrew J., et al.
Publicado: (1993)

Successful surgical treatment for intrahepatic arterioportal fistula with severe portal hypertension: a case report
por: Takata, Hideyuki, et al.
Publicado: (2019)

Symptomatic Presentation of Intrahepatic Portal Vein Aneurysm
por: Philips, Cyriac Abby, et al.
Publicado: (2014)

Intrahepatic portal-venous shunts during PVE
por: Sanampudi, Sreeja, et al.
Publicado: (2018)

Intrahepatic and portal venous gas detected by ultrasonography
por: Bömelburg, T., et al.
Publicado: (1992)

Investigation gene and microRNA expression in glioblastoma
por: Dong, Hua, et al.
Publicado: (2010)

microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
por: Jiao, Xueqiao, et al.
Publicado: (2019)

Therapeutic implications of microRNAs in pulmonary arterial hypertension
por: Lee, Aram, et al.
Publicado: (2014)

Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
por: Zhang, Mei-Yin, et al.
Publicado: (2015)

Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant)
por: Wan, Yue-Meng, et al.
Publicado: (2017)

Intrahepatic portal vein variant: a single dilated intrahepatic portal vein coursing to the umbilical fissure without second-order branches
por: Wang, Yuxin, et al.
Publicado: (2022)

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
por: Kim, Hyung Ki, et al.
Publicado: (2014)

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013)

Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series
Publicado: (2021)

Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats
por: Zhang, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9dvik5pdksig7hr1mld8soqfko